PsychologyAugust 7, 2026
ivonescimab
eye-VON-uh-si-mab
Definition
A bispecific antibody used in cancer treatment, designed to target two distinct pathways simultaneously to inhibit tumor growth.
Etymology
The name is a constructed scientific term following standard pharmaceutical nomenclature; the '-mab' suffix identifies it as a monoclonal antibody, derived from the acronym for monoclonal antibody.
In the news
The article mentions ivonescimab in the context of a new clinical trial investigating its use in combination with enfortumab vedotin for treating urothelial carcinoma. It represents an evolving therapeutic strategy in modern oncology research.
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
Read the full article ↗Urology Times